首页 | 本学科首页   官方微博 | 高级检索  
检索        

化积胶囊抗肝纤维化的临床研究
引用本文:王兰青,李坤,吴国志,刘晓燕.化积胶囊抗肝纤维化的临床研究[J].光明中医,2011(10):2060-2062.
作者姓名:王兰青  李坤  吴国志  刘晓燕
作者单位:1. 山东青岛市海慈医疗集团肝胆内科(青岛266033)
2. 山东青岛市海医疗集团预防保健科(青岛266033)
摘    要:目的评价中药化积胶囊抗肝纤维化临床疗效。方法 120例早期乙肝肝硬化患者随机分为2组:中药化积胶囊治疗组60例,大黄蛰虫胶囊对照组60例,治疗6个月。观察治疗前后两组患者的症状、体征、肝功能、血清肝纤维化指标及肝脾影像学变化。结果治疗组总有效率为93.34%,对照组总有效率为80.01%,两组比较具有显著性差异(P〈0.01)。结论化积胶囊可明显改善早期乙肝肝硬化患者的症状、体征、肝功能、血清肝纤维化4项指标(HA、LN、PCIII及IV-C)、及肝脾影像学表现,具有明显抗肝纤维化疗效。

关 键 词:早期乙肝肝硬化  化积胶囊  抗肝纤维化  临床研究

The Clinical Study of Huaji Capsule on Resisting Hepatic Fibrosis
Wang Lanqing,Li Kun,Wu Zhiguo,LIU Xiaoyan.The Clinical Study of Huaji Capsule on Resisting Hepatic Fibrosis[J].Journal of Traditional Chinese Medicine,2011(10):2060-2062.
Authors:Wang Lanqing  Li Kun  Wu Zhiguo  LIU Xiaoyan
Institution:Wang Lanqing1 Li Kun2 Wu Zhiguo1 LIU Xiaoyan1 (Qingdao Hiser Medical Group,Qingdao Shandong 266033,China)
Abstract:Objective To evaluate the clinical curative effect caused by Huaji capsule in terms of anti-hepatofibrosis.Method one hundred twenty patients with fore-hepatocirrhosis due to chronic hepatitis B were divided into two groups at random.: treatment (Huaji capsule ) group was 60 cases,control (Dahuan Zhechong capsule ) group was 60 cases.After 6 months treatment,to observe the change of clinical symptoms,signs,hepatic function,hepatofibrosis indexes in serum,and B-ultrasonography of liver and spleen.Results The...
Keywords:fore-hepatofibrosis/chronic hepatitis B  Huaji capsule  resist hepatic fibrosis  clinical study  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号